Indeed, treatment was associated with a reduction of mMDSC and Treg in the blood and at the tumor site, an increase in the expression of CD3ζ chain at the tumor site and a higher infiltration of activated CD8+ T cells at the tumor site (Figures 3, 5). This evidence concerns the gene CD247 and neoplasm.